Changes in the levels of proteins related to Aβ metabolism, including an increase in APP and β-secretase levels and a decrease in α-secretase levels, have been widely reported in AD patients and animal models (Xiong et al., 2011; Lichtenthaler et al., 2021). This evidence concerns the gene APP and Alzheimer disease.